Bladder Cancer Detection Kits Market to Witness CAGR of 11% (2022-2028) Due to Increasing Cases of Urothelial Carcinoma in Kidney and Ureter | Daily News Byte

NOIDA, India, December 21, 2022 /PRNevsvire/ — According to a new report published by UnivDatas Markets Insights, Bladder Cancer Detection Kit Market was valued at 125 million dollars and is expected to grow at a CAGR of around 11% from 2022-2028. The analysis is divided into technology (fluorescence in situ hybridization (FISH), enzyme-linked immunosorbent assay (ELISA), other); Type (blood sample test, urine sample test, cell sample test); End user (hospitals and clinics, diagnostic center, home care, research centers, others); Region/Country.

Click here to view the report description and TOC

https://univdatos.com/report/bladder-cancer-detection-kit-market/

The Bladder Cancer Detection Kits market report is aggregated by gathering informative data on various dynamics such as market drivers, restraints, and opportunities. This innovative report uses several analyzes to provide a closer look at the Bladder Cancer Detection Kits market. Bladder Cancer Detection Kits Market report offers detailed analysis of latest industry developments and market trending factors influencing the growth of the market. Furthermore, this statistical market research repository examines and evaluates the Bladder Cancer Detection Kits market on a global and regional level.

Request for sample pages

https://univdatos.com/get-a-free-sample-form-php/?product_id=27745

Market overview

The bladder cancer detection kits market in hospital infrastructure is globally driven by innovation. Investors building hospitals to detect and treat cancer are tapping into the bladder cancer market.

Bladder cancer detection kits market is expected to grow at a constant rate of around 11% due to increasing prevalence of bladder cancer. According to the World Cancer Research Fund (VCRF), about 275,000 people are diagnosed with bladder cancer each year, and about 108,000 people die from bladder cancer worldwide. Furthermore, bladder cancer is the sixth most common cancer in men and the 17th most common cancer in women worldwide..

Some of the major players operating in the market are Cepheid, BIOSINEX SA, Abbott Laboratories, EKSACT Sciences Corporation, Abingdon Health PLC, Xiamen Biotime Biotechnologi Co., Ltd., IDL Biotech AB, Alfa Scientific Designs, Biomerica Inc, Hologic Inc.

The story continues

Impact of COVID-19

During the period of isolation, the healthcare business experiences unusual situations. The closing of production facilities affected the creation of medical articles. Supply chain execution, regulatory and policy changes, workforce reliance, working capital management, and liquidity and solvency management are all major concerns for bladder cancer detection kit manufacturers. In terms of mortality rates, bladder cancer cases are outpacing those of COVID-19 worldwide and may reach as high as 52% in 2020.

The global Bladder Cancer Detection Kits market report is thoroughly studied with several aspects that would help the stakeholders to make their decisions more curatively.

• On the basis of type, the market is segmented into fluorescence in situ hybridization (FISH), enzyme-linked immunosorbent assay (ELISA), and others. The fluorescence in situ hybridization (FISH) category witnessed a significant CAGR during the forecast period. This segment is expected to take the lead as it is a unique urine testing technology that uses fluorescent directly labeled DNA probes to detect genetic abnormalities in urothelial cells detected in urine.

• On the basis of end user, the market is categorized into hospitals and clinics, diagnostic centers, home care, research centers and others. Among them are hospitals and clinics that will hold a significant share of the market in 2020. The market for bladder cancer detection kits in hospital infrastructure is driven by innovation globally. Investors building hospitals to detect and treat cancer are tapping into the bladder cancer market.

See Chapters https://univdatos.com/report/bladder-cancer-detection-kit-market/

Geographical Segmentation of the Bladder Cancer Detection Kits Market includes:

• North America (America, Canadaand the rest North America)

• Europe (Germany, United Kingdom, Spain, Italy, Franceand the rest Europe)

• Asia-Pacific (China, Japan, Indiaand the rest Asia-Pacific)

• The rest of the world

North America expected to grow at a significant CAGR during the forecast period. This is mainly attributed to the growing prevalence of bladder cancer across the region driving the bladder cancer detection kits market in North America. According to the American Cancer Society, approximately 83,730 new cases of bladder cancer and approximately 17,200 bladder cancer deaths occurred in the US in 2020. Furthermore, the growth of the bladder cancer detection kits market in these regions is expected to be further supported by increased investment in research and development, improvement in healthcare infrastructure, and multiple government initiatives.

Major players targeting the market include

• Cepheid

• BIOSINEX SA

• Abbott Laboratories

• EXACT Sciences Corporation

• Abingdon Health PLC

• Xiamen Biotime Biotechnology Co., Ltd.

• IDL Biotech AB

• Alpha Scientific Designs

• Biomerica Inc

• Hologic Inc.

The competitive landscape

The degree of competition among prominent global companies is elaborated by analyzing several leading key players operating worldwide. A specialist team of research analysts shed light on various features such as global market competition, market share, latest industry developments, innovative product launches, partnerships, mergers or acquisitions of leading companies in Bladder Cancer Detection Kit market. Major players are analyzed using research methodologies to gain insight into global competition.

Key questions addressed through this market analytics research report include:

• What are the latest trends, new patterns and technological advancements in Bladder Cancer Detection Kits market?

• What Factors Influence the Bladder Cancer Detection Kits Market During the Forecast Period?

• What are the global challenges, threats, and risks in the Bladder Cancer Detection Kit market?

• What Factors Drive and Restrain the Bladder Cancer Detection Kits Market?

• Which are the demanding regions of the global Bladder Cancer Detection Kit market?

• What will be the size of the global market in the coming years?

• What are the key market acquisition strategies and policies employed by global companies?

We understand the requirements of different companies, regions and countries, we offer customized reports according to your requirements of business nature and geography. Please let us know if you have any custom needs.

About UnivDatas Market Insights (UMI)

Browse other related research reports from UnivDatas Market Insights

Bladder Cancer Detection Kit Market Coverage of the report

About UnivDatas Market Insights (UMI)

UnivDatos Market Insights (UMI) is a passionate market research firm and a subsidiary of Universal Data Solutions. We believe in providing insights through market intelligence reports, custom business research and primary research. Our research studies are distributed across topics worldwide, covering markets in over 100 countries using smart research techniques and agile methodologies. We offer in-depth studies, in-depth analysis and customized reports that help shape winning business strategies for our clients.

Contact
UnivDatas Market Insights
Ankita Gupta
Director of Operations
Phone: +91-7838604911
Email: Ankita.gupta@univdatos.com
Website: https://univdatos.com/

Logo: https://mma.prnevsvire.com/media/1225049/UnivDatos_Logo.jpg

See original content: https://www.prnevsvire.com/nevs-releases/bladder-cancer-detection-kit-market-to-witness-cagr-of-11-2022-2028-due-to-the-rising- urothelial-cancer-cases-in-kidneys-and-ureters–univdatos-market-insights-301708034.html

SOURCE UnivDatos Market Insights Pvt. doo